TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Difference in mean VEP amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain Consultation Participation Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pain Care Participation Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum galectin-9 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute bioavailability (F) as percent F (%F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of BAY2927088 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of BAY2927088 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Autonomic Symptom Scale 31
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified Schober's Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Get-up-and-Go Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Skills in Laparoscopic Surgery using GOALS scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in the Objective Structured Assessment of Technical Skills (OSATS) global rating scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recent Use of Health Services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Perceived susceptibility of developing alcohol use disorder
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change on Implementation Leadership Scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change on Implementation Climate Scale
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Acoustic Voice Analyze measurements; Motor Speech Profile (MSP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Acoustic Voice Analyze measurements; Multi-dimensional voice program (MDVP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Acoustic Voice Analyze measurements; Analysis of dysphonia in speech and voice (ADSV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Acoustic Voice Analyze measurements; Acoustic Voice Quality Index (AVQI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: evolution of pulmonary infiltrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of treatment emergent AE/SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Medical Outcome Study 36-item Short Form Health Survey (SF-36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Needs and Provision Complexity Scale
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Behavioral Rating Inventory of Executive Function- Adult Version
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: AUC last of JLP-2004
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days hospitalized in the medical intensive care unit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: number of patients who had postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: number of patients who received blood products
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Nitric oxide lung diffusing capacity (DLNO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reverse remodelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Partner's quality of life score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: learning curve of U-EMR application
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Respiratory flow performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total amount of morphine consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Maximal oxygen uptake performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Power performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of survival
Endpoint domain: Mortality/survival
Primary endpoint: Day to stop abnormal uterine bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Patient Health Questionnaire (PHQ-9) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Quick Inventory of Depressive Symptoms (QIDS) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Assessment of Quality of Life (AQoL-8D) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in MATRICS Consensus Cognitive Battery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in the ratio of femoral vein diameter to femoral artery diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: FLACC pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posttraumatic Stress Disorder Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fasting insulin resistance in the morning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose tolerance assessed as glucose concentration 120 minutes after a glucose bolus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Development rate to blastocysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower extremity functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in brain NAD levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depressive symptoms (CDI-2 and BDI-II)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depressive symptoms (PHQ-9)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mindful Attention Awareness Scale (MAAS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: added value of meditation programme
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of students infected with COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Number of staff infected with COVID-19
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in anxiety in students
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in anxiety in staff
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in depression in students
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change in depression in staff
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Residual kidney function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change of Wisconsin Card Sorting Test Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Lower Levels of Spontaneous Reactive Oxygen Species (ROS) Production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain intensity on NPRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive Symptoms Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the BMI Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Body fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bowel activity (bowel sounds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of dose-limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate and severity of adverse events (AEs) and severe adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate and severity of clinically-significant abnormalities in laboratory testings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stent-related symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients using radium-223 with abiraterone acetate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients using radium-223 with other systemic therapies
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of patients using radium-223 without prior systemic therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Anxiety changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depressive mood changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall response rate (RR%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease control rate (DR%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QLQ-C30 Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Area under the serum concentration-time curve from time 0 to infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients using guideline concordant smoking cessation medication at 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reporting smoking cessation abstinence (7 day point prevalence at 6 months)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety Means
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fear Means
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Static Physician Global Assessment score (sPGA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast: Area Under the Plasma Concentration-time Curve From Time 0 to the Time of the Last Quantifiable Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evolution of agitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients who achieved the target level of analgesia and sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of invasive mechanical ventilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unsatisfactory Pap smear rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of blastocyst
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute Effect on Resting Energy Expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prolonged Effect on Resting Energy Expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Acute Effect on Substrate Oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prolonged Effect on Substrate Oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bilateral endoscopic Nasal Polyps Score (NPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal Congestion/Obstruction Symptom Severity (NCS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Work Role Functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Differences in vessel geometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Preference for Same Type of Cast
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Biomarkers of positive initial response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PO2/FIO2 (P/F) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oral Mucositis Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage safe discharge by 4 hours
Endpoint domain: Mortality/survival
Primary endpoint: safety defined as type 1 MI and CV death
Endpoint domain: Mortality/survival
Primary endpoint: Change in the rate of measurements of Age marker Albumin post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the rate of measurements of Age marker fasting glucose post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the rate of measurements of Age marker Creatinine post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in the rate of measurements of Age marker C-Reactive Protein post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in the rate of measurements of Age marker Alkaline Phosphatase post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Apnea severity classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful ILR implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ILR related complications
Endpoint domain: Adverse events/effects
Primary endpoint: macromolecular proton fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proton density fat fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fatty acid composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake of palatable snack
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 360 degree rotation test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5 times Squat Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of DAPI-positive cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %Ki67-positive cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: %CC3-positive cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to ASA over 90 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Measurement of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Temporomandibular Joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of personalized evidence-based medicine recommendations
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neck Functional Disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the NRS curve at rest during 0-24h postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change of intraocular pressure (IOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placental elasticity in kilopascals (kPa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placental viscosity in Pascal.seconde (Pa.s)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Saccade/antisaccade latency difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Error rate of saccade/antisaccade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transcriptomic profile change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of muscle thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term LBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accumulated workdays and LBP
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Long-term LBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average scores of the most severe pain post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset time of pain relief post-dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients satisfied with pain relief post-dose
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of postpartum women
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength of hip muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Incidence of DLTs (Dose-limiting Toxicity)
Endpoint domain: Adverse events/effects
Primary endpoint: Effects of liver cirrhosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Condition of other organs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: uptake of HCV antibody testing
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety (CTCAE v5.0)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in stool microbiome diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in stool microbiome composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of diagnosing sleep disordered breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Alpha Galactosidase level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lyso-GB3 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin quality assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Nutritional Risk Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ostomy compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change of middle cerebral artery pulsatility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptance rate of participation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Three-dimensional implant placement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Graded-Redefined Assessment of Strength, Sensibility, and Prehension (GRASSP) Prehension Performance (GR-PP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manual Muscle Test (MMT) with FES
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VABS2 total score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VABS2 socialization score
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: VABS2 communication score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: VABS2 daily living score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VABS2 motricity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Systemic Mastocytosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Heartbeat Evoked Potential (HEP) for attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Heartbeat Evoked Potential (HEP) for arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Heartbeat Evoked Potential (HEP) for decision making
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful bone defect reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in length of hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Percent of Time in Range (TIR 70-180 mg/dL [3.9 -10.0 mmol/L])
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak oxygen intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronotropic response to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: UPDRS / UMSARS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes